Absence of Negative Impact of Levetiracetam on Cognitive Function and Memory in Normal and Amygdala-Kindled Rats

Epilepsy and Behavior

Volumn 1, Issue 5, 2000, Pages 333-342

  Lamberty, Yves ^a   Margineanu, Doru Georg ^a   Klitgaard, Henrik ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Levetiracetam; valproate; clonazepam; carbamazepine; Morris water maze; cognitive function; memory; long term potentiation; amygdala kindling; antiepileptic drugs

Indexed keywords

EID: 0001025962     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2000.0098     Document Type: Article

References (38)

1. Hermann B, Wyler A, Somes G, Berry A, Dohan F. Pathological status of the mesial temporal lobe predicts memory outcome from left anterior lobectomy. Neurosurgery. 31:1992;652-657.
2. Thompson P J, Corcoran R. Everyday memory failures in people with epilepsy. Epilepsia. 33:1992;S18-S20.
3. Lynch M W, Rutecki P A, Sutula T P. The effects of seizures on the brain. Curr Opin Neurol. 9:1996;97-102.
4. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia. 36:1995;S46-S65.
5. Trimble M R, Thompson P J. Memory, anticonvulsant drugs and seizures. Acta Neurol Scand Suppl. 89:1981;31-41.
6. Becker A, Grecksch G, Brosz M. Antiepileptic drugs: their effects on kindled seizures and kindling-induced learning impairments. Pharmacol Biochem Behav. 52:1995;453-459.
7. Zola-Morgan S, Squire L R. Neuroanatomy of memory. Annu Rev Neurosci. 6:1983;547-563.
8. Leonard B, Mc Naughton B L. Spatial representation in the rat: conceptual, behavioral, and neurophysiological perspectives. Kesner R P, Olton D S. Neurobiology of comparative cognition. 1990;Erlbaum, Hillsdale.
9. Morris R GM. Spatial localization does not require the presence of local cues. Learn Motiv. 12:1981;239-261.
10. Hort J, Brozek G, Mares P, Langmeier M, Komarek V. Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures. Epilepsia. 40:1999;1177-1183.
11. Bliss T VP, Collingridge G L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
12. Lee G YP, Brown L M, Teyler T J. The effects of anticonvulsant drugs on long-term potentiation (LTP) in the rat hippocampus. Brain Res Bull. 39:1996;39-42.
13. Klitgaard H, Matagne A, Gobert J, Wulfert E. Evidence for a unique preclinical profile of levetiracetam in rodents models of seizures and epilepsy. Eur J Pharmacol. 353:1998;191-206.
14. Löscher W, Honack D. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol. 232:1993;147-158.
15. Löscher W, Honack D, Rundfeldt C. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy. J Pharmacol Exp Ther. 284:1998;474-479.
16. Paxinos G, Watson C. The rat brain in stereotaxic coordinates, 2nd ed. 1986;Academic Press, San Diego.
17. Racine R J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 32:1972;281-294.
18. Hönack D, Löscher W. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia. 36:1995;763-771.
19. Cammisuli S, Murphy M P, Ikeda-Douglas C J, Balkissoon V, Holsinger R MD, Head E, Michael M, Racine R J, Milgram N W. Effects of extended electrical kindling on exploratory behavior and spatial learning. Behav Brain Res. 89:1997;179-190.
20. Margineanu D G, Niespodziany I, Wülfert E. Hippocampal slices from long-term streptozotocin-injected rats are prone to epileptiform responses. Neurosci Lett. 252:1998;183-186.
21. Löscher W, Schmidt D. Which animal models should be used in search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
22. Patsalos P N. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 85:2000;77-85.
23. Margineanu, D, G, Klitgaard, H, Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs, Pharmacol Res, 2000, in press.
24. Dagnelie P. Theorie et méthodes statistiques. 1985;J. DuculotS.A. Gembloux.
25. Matagne A, Klitgaard H. Validation of corneally kindled mice: a sensitive screening model for partial epilepsy in man. Epilepsy Res. 31:1998;59-71.
26. Balakrishnan S, Pandhi P. Effect of nimodipine on the cognitive dysfunction induced by phenytoin and valproate in rats. Methods Find Exp Clin Pharmacol. 19:1997;693-697.
27. Hudzik T J, Palmer G C. Effects of anticonvulsants in a novel operant learning paradigm in rats: comparison of remacemide hydrochloride and FPL 15896A to other anticonvulsant agents. Epilepsy Res. 21:1995;183-193.
28. Willner P, Birbeck K A. Effect of chlordiazepoxide and sodium valproate in two tests of spatial behaviour. Pharmacol Biochem Behav. 25:1986;747-751.
29. Löscher W, Hönack D. Anticonvulsant and behavioural effects of two novel competitive N-methyl-d-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy: comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther. 256:1991;432-440.
30. Margineanu D G, Wülfert E. ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo. Eur J Pharmacol. 286:1995;321-325.
31. Birnstiel S, Wülfert E, Beck S G. Levetiracetam (L059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission. Naunyn-Schmiedeberg's Arch Pharmacol. 356:1997;611-618.
32. Meador K J, Loring D W, Moore E E, Thompson W O, Nichols M E, Oberzan R E, Durkin M W, Gallagher B B, King D W. Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology. 45:1995;1494-1499.
33. Thompson P J. Antiepileptic drugs and memory. Epilepsia. 33:1992;S37-S40.
34. Trimble M R. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia. 28:1987;S37-S45.
35. Drane D L, Meador K J. Epilepsy, anticonvulsant drugs and cognition. Baillieres Clin Neurol. 5:1996;877-885.
36. Forsythe I, Butler R, Berg I, McGuire R. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol. 33:1991;524-534.
37. Neyens L GJ, Alpherts W CJ, Aldenkamp A P. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuro-Psychopharmacol Biol Psychiatry. 19:1995;411-419.
38. Cramer J A, Arrigo C, Van Hammée G, Gauer L J, Cereghino J J. Effect of levetiracetam on epilepsy-related quality of life. Epilepsia. 41:2000;868-874.